Skip to main content

Table 3 Association between the presence or absence of the duct of Santorini or ansa pancreatica and IPMN disease

From: Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study

 

IPMN group (n = 98)

Control group (n = 100)

OR (95% CI)

P value

Duct of Santorini

55 (64.7%)

30 (35.3%)

3.93 (2.09–7.39)

 < 0.001

Ansa pancreatica

15 (60.0%)

10 (40.0%)

3.21 (1.28–8.04)

0.013

Both absent

28 (31.8%)

60 (68.2%)

1

 
  1. Logistic regression results are reported as odds ratio (OR, outcome is IPMN, control as the reference group) with 95% confidence intervals (CI) and P-value. The “both absent” group is used as the reference. Patients with pancreas divisum excluded
  2. CI, confidence interval; IPMN, intraductal papillary mucinous neoplasm; OR, odds ratio
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us